menu
    • menu

    Company profile for Hasten Biopharmaceutic

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Hasten Biopharmaceutic Company Limited (Hasten Biopharma), which integrates R&D, production and commercial promotion and covers the whole industrial chain, was established in 2020. Hasten is jointly invested and established by CBC Group, one of the largest healthcare-dedicated investment firms in Asia, Hefei Industry Investment Group and Feidong County, Hefei City. Originated from the world's leading biopharmaceutical company...
    Hasten Biopharmaceutic Company Limited (Hasten Biopharma), which integrates R&D, production and commercial promotion and covers the whole industrial chain, was established in 2020. Hasten is jointly invested and established by CBC Group, one of the largest healthcare-dedicated investment firms in Asia, Hefei Industry Investment Group and Feidong County, Hefei City. Originated from the world's leading biopharmaceutical company Takeda, the 5 star products in the field of cardiovascular and metabolism provide patients with chronic diseases health care supports as needed.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Hasten BiopharmaceuticChina Flag
    Country
    Country
    China
    Address
    Address
    17# Build, 1 Chang Lin River Ke Chuang Village, Hefei, Anhui
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.hastenpharma.com/en/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Chinese startup Hasten Biopharma buys 14 products from Korean firm Celltrion
    Chinese startup Hasten Biopharma buys 14 products from Korean firm Celltrion

    02 Jul 2024

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/25/24511/chinese-startup-hasten-biopharma-buys-14-products-from-korean-firm-celltrion-.html

    BIOSPECTRUM ASIA
    02 Jul 2024
    Share Share
    LIB & Partner Hasten Announce Lerodalcibep Clinical Trial
    LIB & Partner Hasten Announce Lerodalcibep Clinical Trial

    19 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240319575767/en

    BUSINESSWIRE
    19 Mar 2024
    Share Share
    LIB Therapeutics and Hasten Company Announce $325 Million Collaboration
    LIB Therapeutics and Hasten Company Announce $325 Million Collaboration

    12 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230912938222/en

    BUSINESSWIRE
    12 Sep 2023
    Share Share
    Hasten acquires commercial rights in China for Roche's antibiotic Rocephin
    Hasten acquires commercial rights in China for Roche's antibiotic Rocephin

    05 May 2023

    // BIOSPECTRUMASIA

    https://www.biospectrumasia.com/news/25/22393/hasten-biopharma-acquires-commercial-rights-in-china-for-roches-antibiotic-rocephin.html

    BIOSPECTRUMASIA
    05 May 2023
    Share Share
    Hasten Acquires Commercial Rights in China for Roche's Antibiotic Rocephin®
    Hasten Acquires Commercial Rights in China for Roche's Antibiotic Rocephin®

    04 May 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hasten-biopharma-acquires-commercial-rights-in-china-for-roches-antibiotic-rocephin-301814765.html

    PR NEWSWIRE
    04 May 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search